This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/kegg-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/drugbank/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03913/identifier/chebi/

Statements

Subject Item
n2:DB03913
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB03913 n15:DB03913
dcterms:title
Coenzyme F420
adms:identifier
n9:46936827 n10:46504684 n11:C00876 n12:F42 n13:16848 n14:DB03913
n3:IUPAC-Name
n4:271B4F21-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4F27-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4F26-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4F23-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4F24-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4F25-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4F1F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4F1D-363D-11E5-9242-09173F13E4C5 n4:271B4F20-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4F1E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4F2D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4F2E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4F28-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4F29-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4F2B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4F2A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4F2C-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
64885-97-8
n3:Bioavailability
n4:271B4F33-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4F35-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4F36-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4F32-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4F31-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4F34-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4F22-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4F2F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4F30-363D-11E5-9242-09173F13E4C5